GlassScriptPhysician profile
Arya Karki
NPI 1750532156
$1,616.51
in general payments reported to CMS, 2019-2025
18 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $77.57 · 2021: $195 · 2022: $312 · 2023: $454 · 2024: $290 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869 · Gift: $20.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.41 |
| Gift | $20.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $492.21 | 2019-2025 | |
| Celgene Corporation | $256.26 | 2021-2023 | Zeposia |
| Genzyme Corporation | $146.39 | 2023-2025 | |
| Pfizer INC. | $126.77 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $124.31 | 2023-2024 | Dificid |
| Intercept Pharmaceuticals, INC. | $68.25 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $61.24 | 2019-2024 | Linzess |
| Nestle Healthcare Nutrition INC. | $59.53 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $58.20 | 2022-2024 | Dupixent |
| Janssen Biotech, INC. | $39.90 | 2020-2021 | |
| Boston Scientific Corporation | $38.28 | 2023 | Watchman Flx |
| Braintree Laboratories, INC. | $32.31 | 2021-2024 | Suflave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.45 | 2019-2022 | |
| Daiichi Sankyo INC. | $24.81 | 2021 | |
| Novo Nordisk INC | $16.64 | 2024 | Wegovy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $15.04 | 2025 | Ibsrela |
| Shionogi INC | $14.06 | 2019 | |
| Intra-Sana Laboratories | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arya Karki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.